B.R.A.I.N. Biotechnology Research And Information Network AG (ETR:DE000520) | WebDisclosure

Basculer en Français

11141	Companies
245433	Keywords
173480	Articles
132410	Press releases

Headlines Articles Press releases B.R.A.I.N. Biotechnology Research And Information Network AG

Home
Companies
B.R.A.I.N. Biotechnology Research And Information Network AG

PRESS RELEASE

published on 05/28/2026 at 07:30, 4 months 9 days ago

BRAIN Biotech AG reports half-year figures for fiscal year 2025/26 and confirms full year guidance
BRAIN Biotech AG reports half-year figures for fiscal year 2025/26, with sequential growth in core segment BRAINBiocatalysts and a new European patent for genome editing. Full year guidance confirmed

Financial Forecast Half-year Results BRAIN Biotech AG EU Patent Genome Editing
BRIEF

published on 03/23/2026 at 11:10, 6 months 14 days ago

BRAIN Biotech obtient un brevet pour la technologie CRISPR-BMC

BRAIN Biotech Édition Du Génome Brevet Accordé CRISPR-BMC Potentiel De Licences
BRIEF

published on 03/23/2026 at 11:10, 6 months 14 days ago

BRAIN Biotech Secures Patent for CRISPR-BMC Technology

BRAIN Biotech Genome-editing CRISPR-BMC Patent Granted Licensing Potential
PRESS RELEASE

published on 03/23/2026 at 11:05, 6 months 14 days ago

BRAIN Biotech has been granted a key patent for its CRISPR-BMC genome-editing technology
BRAIN Biotech secures key patent for CRISPR-BMC genome-editing technology, opening potential for commercial use through licensing. Nuclease exhibits high activity in various organisms

Patent BRAIN Biotech Licensing CRISPR-BMC Genome-editing Technology
BRIEF

published on 03/11/2026 at 17:10, 6 months 26 days ago

BRAIN Biotech AG 2026 AGM Results

Annual General Meeting Supervisory Board BRAINBiocatalysts Two-pillar Strategy Enzyme Production
BRIEF

published on 03/11/2026 at 17:10, 6 months 26 days ago

Résultats de l'assemblée générale annuelle 2026 de BRAIN Biotech AG

Conseil De Surveillance Assemblée Générale Annuelle Stratégie À Deux Piliers Biocatalyseurs CÉRÉBRAUX Production D'enzymes
PRESS RELEASE

published on 03/11/2026 at 17:05, 6 months 26 days ago

Results of the 2026 Annual General Meeting for the 2024/25 financial year of BRAIN Biotech AG
Results of the 2026 Annual General Meeting for the 2024/25 financial year of BRAIN Biotech AG. Shareholders approve all agenda items. New member elected to the Supervisory Board. CEO highlights company's strategy and unique selling points

Annual General Meeting Financial Year Supervisory Board BRAIN Biotech AG Product Innovations
BRIEF

published on 02/25/2026 at 07:35, 7 months 9 days ago

BRAIN Biotech Reports Q1 Results and SolasCure's Clinical Milestone

Financial Performance BRAIN Biotech Q1 Results SolasCure Aurase Wound Gel
BRIEF

published on 02/25/2026 at 07:35, 7 months 9 days ago

BRAIN Biotech publie ses résultats du premier trimestre et SolasCure franchit une étape clinique importante

Performance Financière BRAIN Biotech Résultats Du Premier Trimestre SolasCure Gel Pour Plaies Aurase
PRESS RELEASE

published on 02/25/2026 at 07:30, 7 months 9 days ago

BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure: Aurase Wound Gel showing strong clinical evidence of superior debridement and healing in chronic wounds
BRAIN Biotech's Q1 25/26 results show revenue decline but improved EBITDA. Breakthrough Aurase Wound Gel by SolasCure for chronic wounds. BRAIN BioIncubator segment thrives

EBITDA BRAIN Biotech Q1 Results SolasCure Aurase Wound Gel

Accesswire

Published on 10/07/2026 at 01:45, 4 hours 33 minutes ago

Final Tunkillia Assays Among the Best Infill Results To-Date, with Broad, High-Grade Intersections Throughout 'Starter Pit' Outlines
Published on 10/07/2026 at 01:30, 4 hours 48 minutes ago

ECC Ventures 4 Corp. Announces Resumption of Trading
Published on 10/07/2026 at 01:05, 5 hours 13 minutes ago

Alaska Energy Metals Reports on At-The-Market Equity Financing Program
Published on 10/06/2026 at 23:45, 6 hours 33 minutes ago

Gamma Resources Closes $1,750,000 Private Placement
Published on 10/06/2026 at 23:32, 6 hours 46 minutes ago

Battery X Metals Announces Closing of First Tranche of Private Placement Financing

View all ACCESSWIRE

EQS Group

Published on 10/06/2026 at 19:05, 11 hours 12 minutes ago

Cambridge Heartwear Awarded £184 Million NHS Tender for World's First Medical-Grade, Wirelessly Charged, Reusable ECG Wearable
Published on 10/06/2026 at 18:30, 11 hours 47 minutes ago

Avolta’s Hudson secures new 20-year duty-free contract at Seattle-Tacoma International
Published on 10/06/2026 at 18:05, 12 hours 13 minutes ago

Lepermislibre: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
Published on 10/06/2026 at 18:00, 12 hours 17 minutes ago

ARVERNE GROUP: Nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2026
Published on 10/06/2026 at 18:00, 12 hours 17 minutes ago

ARVERNE GROUP: Total number of shares and voting rights in the share capital as of September 30, 2026

Les Echos

Published on 10/06/2026 at 19:15, 11 hours 3 minutes ago

Air Liquide has successfully issued a 2 billion euros multi-tranche bond
Published on 10/06/2026 at 19:15, 11 hours 3 minutes ago

Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 2 milliards d’euros
Published on 10/06/2026 at 18:39, 11 hours 38 minutes ago

Capital et droits de vote au 30 septembre 2026
Published on 10/06/2026 at 18:39, 11 hours 38 minutes ago

Total number of voting rights and shares making up the share capital at September 30, 2026
Published on 10/06/2026 at 18:15, 12 hours 3 minutes ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 30/09/2026

View all LES ECHOS COMFI WIRE